Cryptococcal Meningitis Clinical Trials

34 clinical trials for Cryptococcal Meningitis across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia — RECRUITING
• Fungal Infection Susceptibility — RECRUITING
• Platform Trial For Cryptococcal Meningitis (PLATFORM-CM) — RECRUITING · PHASE2
• Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia — RECRUITING · PHASE2
• Amphotericin B for Non-HIV Cryptococcal Meningitis Patients — RECRUITING · PHASE4
• Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers — NOT_YET_RECRUITING · PHASE3
• Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis — COMPLETED · PHASE2
• Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) — COMPLETED · PHASE1
• Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City — OTHER · NA
• Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 — OTHER · PHASE3
• Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis — OTHER · NA
• Driving Reduced AIDS-associated Meningo-encephalitis Mortality — COMPLETED · NA
• Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis — COMPLETED
• The Lived Experience of Participants in an African Randomised Trial — COMPLETED
• High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals — COMPLETED · PHASE1
• Three Induction Treatments on Cryptococcal Meningitis — OTHER · PHASE1
• Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis — COMPLETED · PHASE3
• Cryptococcal Optimal ART Timing Trial — COMPLETED · PHASE4
• Operational Research for Cryptococcal Antigen Screening — COMPLETED · PHASE4
• AmB Dose for Cryptococcal Meningitis — OTHER · PHASE3
• CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa — COMPLETED
• Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report — COMPLETED · PHASE1
• Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS — OTHER · NA
• Vietnam Cryptococcal Retention in Care Study - Version 2.1 — OTHER
• Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa — COMPLETED · NA
• Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa — OTHER · PHASE2
• Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis — OTHER · PHASE4
• Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC — COMPLETED · PHASE3
• Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis — OTHER · NA
• Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy — COMPLETED
• Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis — COMPLETED · PHASE2
• Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis — COMPLETED · PHASE4
• Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS — TERMINATED · PHASE2
• Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS — TERMINATED · PHASE2

Refine this search